| Project/Area Number |
18H03032
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 58010:Medical management and medical sociology-related
|
|---|
| Research Institution | Hyogo Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
作間 未織 兵庫医科大学, 医学部, 講師 (60349587)
太田 好紀 兵庫医科大学, 医学部, 講師 (10516404)
武内 治郎 兵庫医科大学, 医学部, 助教 (60791324)
|
|---|
| Project Period (FY) |
2018-04-01 – 2021-03-31
|
| Project Status |
Completed (Fiscal Year 2022)
|
| Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2020: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2019: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
Fiscal Year 2018: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
|
|---|
| Keywords | 医原性有害事象 / 医療安全 / 臨床疫学 / 情報科学 / コホート研究 |
|---|
| Outline of Final Research Achievements |
We investigated the clinical epidemiology of adverse events, including the incidences and types, which occur in a daily clinical practice but are overlooked because they are not recognized as iatrogenic. We detected 1147 adverse events occurred in 1130 hospitalized patients, of which 226 (19.7%) were likely looked over during care. The breakdown was 54% adverse drug events, 11% surgery-related adverse events, 8% procedure- or laboratory-related adverse events, 2% decision-related adverse events, 16% nursing-related adverse events, and 5% hospital management-related adverse events, and nosocomial infection 3%.
Our investigation resulted in that the overall picture of adverse events that are overlooked in daily clinical practice would provide the safer medical care in the future.
|
| Academic Significance and Societal Importance of the Research Achievements |
日常的に発生していることが明らかになっている医原性有害事象について、診療中には医原性とは認識されていない有害事象の頻度や種類、健康被害などの臨床疫学を明らかにすることは、より安全な医療を提供するために喫緊の課題である。本研究課題を通じて、わが国の日常診療において、見逃された医原性有害事象の臨床疫学を明らかにすることができ、これらの結果を基に、より安全な医療を提供することに繋がることが期待される。
|
